Skip to main content
NCBI home page
Atencion Primaria logoLink to Atencion Primaria
. 2013 Apr 5;30(5):323–332. [Article in Spanish] doi: 10.1016/S0212-6567(02)79035-5

Tratamiento de la incontinencia urinaria

M Juarranz Sanz a,*, R Terrón Barbosa a, M Roca Guardiola a, T Soriano Llora a, M Villamor Borrego b, MJ Calvo Alcántara b
PMCID: PMC7684188  PMID: 12372215

The content is available as a PDF (358.8 KB).

Bibliografía

  • 1.International Continent Society Standardisation of terminology of lower urinary tract function. Urology. 1997;9:237. [Google Scholar]
  • 2.Badía Llach X., Castro Díaz D., Conejero Sugrañes J. Validez del cuestionario King’s Health para la evaluación de la calidad de vida en pacientes con incontinencia urinaria. Med Clin (Barc) 2000;114:647–652. doi: 10.1016/s0025-7753(00)71390-x. [DOI] [PubMed] [Google Scholar]
  • 3.Shaw C., Tansey R., Jackson C., Hyde C., Allan R. Barriers to help seeking in people with urinary symptoms. Family Practice. 2001;18:48–52. doi: 10.1093/fampra/18.1.48. [DOI] [PubMed] [Google Scholar]
  • 4.Cheater F.M., Castleden C.M. Epidemiology and classification of urinary incontinence. Bailliére’s Best Pract Res Clin Obstet Gynaecol. 2000;14:183–205. doi: 10.1053/beog.1999.0071. [DOI] [PubMed] [Google Scholar]
  • 5.Hunskaar S., Arnold E.P., Burgio K., Diokno A.C., Herzog A.R., Mallett V.T. Epidemiology and natural history of urinary incontinence. Int Urogynecol J Pelvic Floor Dysfunct. 2000;11:301–319. doi: 10.1007/s001920070021. [DOI] [PubMed] [Google Scholar]
  • 6.Damian J., Martín-Moreno J.M., Lobo F., Bonache J., Cerviño J., Redondo-Márquez L. Prevalence of urinary incontinence among Spanish older people living at home. Eur Urol. 1998;34:333–338. doi: 10.1159/000019750. [DOI] [PubMed] [Google Scholar]
  • 7.Indicadores de la prestación farmacéutica en el Sistema Nacional de Salud . Vol 14, año 1996. Instituto Nacional de la Salud. Subdirección General de Coordinación Administrativa; Madrid: 1996. [Google Scholar]
  • 8.Moore K.H. Conservative management for urinary incontinence. Bailliére’s Best Pract Res Clin Obstet Gynaecol. 2000;14:207–226. doi: 10.1053/beog.1999.0074. [DOI] [PubMed] [Google Scholar]
  • 9.Adersson K.E. Drug therapy for urinary incontinence. Baillière’s Best Pract Res Clin Obstet Gynaecol. 2000;14:291–313. doi: 10.1053/beog.1999.0075. [DOI] [PubMed] [Google Scholar]
  • 10.Keane D.P., O’Sullivan S. Urinary incontinence: anatomy, physiology and pathophysiology. Bailliére’s Best Pract Res Clin Obstet Gynaecol. 2000;14:207–226. doi: 10.1053/beog.1999.0072. [DOI] [PubMed] [Google Scholar]
  • 11.Couture J.A., Valiquette L. Urinary incontinence. Ann Pharmacother. 2000;34:646–655. doi: 10.1345/aph.19176. [DOI] [PubMed] [Google Scholar]
  • 12.Ruscin J.M., Morgenstern N.E. Tolterodine use for symptoms of overactive bladder. Ann Pharmacoter. 1999;33:1073–1082. doi: 10.1345/aph.18427. [DOI] [PubMed] [Google Scholar]
  • 13.Steele A.C., Kohli N., Mallipeddi P., Karram M. Pharmacologic causes of female incontinence. Int Urogynecol J Pelvic Floor Dysfunct. 1999;10:106–110. doi: 10.1007/s001920050027. [DOI] [PubMed] [Google Scholar]
  • 14.Badía Lluch X., Castro Díaz D., Cabañas Perales L., Peña Outeriño J.M., Martínez Agullo E., Conejero Sagrañes J. Elaboración y validación preliminar del cuestionario para la clasificación clínica de la incontinencia urinaria IU-4. Actas Urol Esp. 1999;23:565–572. [PubMed] [Google Scholar]
  • 15.Seim A., Hunskaar S. Female urinary incontinence the role of the general practitioner. Acta Obstet Gynecol Scand. 2000;79:1046–1051. [PubMed] [Google Scholar]
  • 16.Bristow S.E., Hilton P. Assessment and investigations for urinary incontinence. Baillière’s Best Pract Res Clin Obstet Gynaecol. 2000;14:227–249. doi: 10.1053/beog.1999.0073. [DOI] [PubMed] [Google Scholar]
  • 17.Verdejo Bravo C., Salinas Casado J., Virseda Chamorro M., Rexach Cano L., Adot Zurbano J.M., Ribera Casado J.M. Hacia un método simplificado de tipificación de la incontinencia urinaria del anciano, basado en el análisis multivariante de 948 casos. Arch Esp Urol. 1999;52:440–450. [PubMed] [Google Scholar]
  • 18.Bo K., Talseth T. Five year follow up of pelvic floor muscle exercice for treatment of stress uri-nary incontinence. Clinical and urodynamic assessment. Neurourol Urodyn. 1995;14:374–376. [Google Scholar]
  • 19.Obrien J., Austin M., Sethi P., O’Boyle P. Uri-nary incontinence: prevalence, need for treatment, and effectiveness of intervention by nurse. BMJ. 1991;303:1308–1312. doi: 10.1136/bmj.303.6813.1308. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Virseda Chamorro M., Salinas Casado J., Salomón Moh’d S., Esteban Fuertes M., Fernández Ajubita H., Ramírez Fernández J.C. Modificación del perfil de presión uretral postelectroestimulación vaginal en el tratamiento de la incontinencia urinaria de esfuerzo. Arch Esp Urol. 1997;50:643–647. [PubMed] [Google Scholar]
  • 21.Fusgen I., Hauri D. Trospium chloride: an effective option for medical treatment of bladder overactivity. Int J Clin Pharmacol Ther. 2000;38:223–234. doi: 10.5414/cpp38223. [DOI] [PubMed] [Google Scholar]
  • 22.Tropium Aucum progrés sur l’oxybutynine, mais les prix flambent. Rev Prescr. 2001;21:414–415. [Google Scholar]
  • 23.Hills C.J., Winter S.A., Balfour J.A. Tolterodine. Drugs. 1998;55:813–820. doi: 10.2165/00003495-199855060-00008. [DOI] [PubMed] [Google Scholar]
  • 24.Rentzhog L., Staton S.L., Cardozo L., Nelson E., Falls M., Abrams P. Efficacy and safety of tolterodine in patients with detrusor instability: a dose-ranging study. Br J Urol. 1998;81:42–48. doi: 10.1046/j.1464-410x.1998.00501.x. [DOI] [PubMed] [Google Scholar]
  • 25.Abrams P., Freeman R., Anderstrom C., Mattiasson A. Tolterodine, a new antimuscarinic agent: as effective but better tolerated than oxybutynin in overactive bladder. Br J Urol. 1998;81:801–810. doi: 10.1046/j.1464-410x.1998.00717.x. [DOI] [PubMed] [Google Scholar]
  • 26.Drutz H.P., Appel R.A., Gleason D., Klimberg I., Radomski S. Clinical efficacy and safety of tolterodine compared to oxybutynin and placebo in patients with overactive bladder. Int Urogynecol J. 1999;10:283–289. doi: 10.1007/s001929970003. [DOI] [PubMed] [Google Scholar]
  • 27.Anderson K.E., Appell R., Cardozo L.D., Chap-ple C., Drutz H.P., Finkbeiner A.E. The paharmacological treament of urinary incontinence. BJU Int. 1999;84:923–947. doi: 10.1046/j.1464-410x.1999.00397.x. [DOI] [PubMed] [Google Scholar]
  • 28.Yarquer Y.E., Goa K.L., Fitton A. Oxybutynin. A review of its pharmacodynamic and pharmacokinetic properties, and its therapeutic use in detrusor instability. Drgs Aging. 1995;6:243–246. doi: 10.2165/00002512-199506030-00007. [DOI] [PubMed] [Google Scholar]
  • 29.Moisey C.U., Stepheson T.P., Brendler C.B. The urodynamic and subjective results of treatment of detrusor instability with oxybutynin chloride. Br J Urol. 1980;52:472–475. doi: 10.1111/j.1464-410x.1980.tb03093.x. [DOI] [PubMed] [Google Scholar]
  • 30.Cardozo L.D., Cooper D., Versi E. Oxybutynin chloride in the management of idiopathic detrusor instability. Neurourol Urodyn. 1987;6:256–257. [Google Scholar]
  • 31.Thüroff J.W., Bunke B., Ebner A. Randomized double-blind, multicenter trial on treatment of frequency, urgency and incontinence related to detrusor hyperactivity: oxybutynin versus propanteheline versus placebo. J Urol. 1991;145:813–817. doi: 10.1016/s0022-5347(17)38459-8. [DOI] [PubMed] [Google Scholar]
  • 32.Iselin C.E., Schmidlin F., Borst F., Rohner S., Graber P.J. Oxybutynin in the treatment of early detrusor instability after trasurethral resection of the prostate. Br J Urol. 1997;79:915–919. doi: 10.1046/j.1464-410x.1997.00138.x. [DOI] [PubMed] [Google Scholar]
  • 33.Brendler C.B., Radebaugh L.C., Mohler J.L. Topical oxybutynin chloride for rlaxation of dys-functional bladders. J Urol. 1989;141:1350–1352. doi: 10.1016/s0022-5347(17)41304-8. [DOI] [PubMed] [Google Scholar]
  • 34.Kaplinsky R., Greenfield S., Wan J., Fera M. Expanded followup of intravesicaloxybutynin use in children with neurogenic bladder. J Urol. 1996;156:753–756. doi: 10.1097/00005392-199608001-00053. [DOI] [PubMed] [Google Scholar]
  • 35.Fehrmann Zumpe P., Karbe K., Blessman G. Using flavoxate as primary medication for patients sufffering from urge symptomatology. Int Urogyneccol J. 1999;10:91–95. doi: 10.1007/pl00004018. [DOI] [PubMed] [Google Scholar]
  • 36.Zubiaur Libano C., Loizaga Iriarte A., Ullate Jaime V., García Sastre E., Arciniega García J., Flores Corral N. Tratamiento médico de la inestabilidad vesical. Nuestra experiencia. Arch Esp Urol. 1997;50:633–642. [PubMed] [Google Scholar]
  • 37.Miller K., Atkin B., Moody M.L. Drug therapy for nocturnal enuresis. Drugs. 1992;44:47–56. doi: 10.2165/00003495-199244010-00004. [DOI] [PubMed] [Google Scholar]
  • 38.Ruffolo R.R., Hieble J.P. Adrenoceptor pharmacology: urogenital applications. Eur Urol. 1999;1:17–22. doi: 10.1159/000052313. [DOI] [PubMed] [Google Scholar]
  • 39.Salinas Casado J., Virseda Chamorro M., Tebla del Pino F., Vázquez Alba D., Adot Zurbano J.M. Incontinencia urinaria en la menopausia. Arch Esp Urol. 2000;53:349–354. [PubMed] [Google Scholar]
  • 40.Hilton P., Tweddel A.L., Mayne C. Oral and intravaginal estrogens alone and in combination with alpha adrenergic stimulation in genuine stress incontinence. Int Urogynaecol J. 1990;12:80–86. [Google Scholar]
  • 41.Jarvis G.J. Surgery for genuine stress incontinence. Br J Obstet Gynaecol. 1994;101:371–374. doi: 10.1111/j.1471-0528.1994.tb11907.x. [DOI] [PubMed] [Google Scholar]
  • 42.Jiménez Calvo J., Hualde Alfaro A., Santiago González de Garibay A., Lozano Uruñuela F., De Pablo Cárdenas A. TVT (cinta libre de tensión) nueva técnica quirúrgica para el tratamiento de la incontinencia de esfuerzo. Arch Esp Urol. 2000;53:9–13. [PubMed] [Google Scholar]

Articles from Atencion Primaria are provided here courtesy of Elsevier

RESOURCES